Suppliers / Mianyang Shengshi Health Technology

Mianyang Shengshi Health Technology

China Updated 9 July 2026

Mianyang Shengshi Health Technology is an API manufacturer based in China. It holds 9 active US drug master files across a filed portfolio of 9 molecules.

9
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Cysteine US FDA 1
D-Serine US FDA 1
Glutamic Acid US FDA 1
Isoleucine US FDA 1
L-Glutamine US FDA 1
Leucine US FDA 1
Levodopa US FDA 1
Lysine US FDA 1
Serine US FDA 1

Also appears on these molecule pages

Questions about Mianyang Shengshi Health Technology

Does Mianyang Shengshi Health Technology hold a US DMF or a CEP?
Mianyang Shengshi Health Technology holds 9 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Mianyang Shengshi Health Technology make?
9 molecules are on record against Mianyang Shengshi Health Technology, including Cysteine, D-Serine, Glutamic Acid and Isoleucine. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Mianyang Shengshi Health Technology comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability